Related Experiment Video
Updated: Dec 25, 2025

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
Published on: October 31, 2025
[Bronchopulmonary dysplasia (BPD)]
1Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Deutschland.
Insights
Bronchopulmonary dysplasia (BPD) has evolved from an old form linked to mechanical ventilation to a new form in premature infants. New BPD survivors face long-term multisystem health challenges.
Area of Science:
- Neonatal medicine
- Pediatric pulmonology
- Developmental biology
Context:
- Bronchopulmonary dysplasia (BPD) is a chronic lung disease affecting premature infants.
- Historically, 'old' BPD resulted from mechanical ventilation and oxygen, causing lung fibrosis.
- Modern surfactant therapy has increased survival, leading to 'new' BPD, characterized by impaired alveolar and capillary development.
Purpose:
- To differentiate between the historical and current forms of BPD.
- To highlight the distinct pathological mechanisms and clinical implications of 'new' BPD.
- To underscore the long-term health consequences for survivors.
Summary:
- 'Old' BPD was a fibroproliferative lung disease in premature infants due to ventilation and oxygen.
- 'New' BPD, emerging with increased survival from surfactant therapy, involves arrested lung development and multisystem immaturity.
- Survivors of 'new' BPD may experience persistent lung, cardiovascular, growth, and neurodevelopmental issues into adulthood.
Impact:
- Understanding the evolution of BPD is crucial for developing targeted therapies.
- Recognizing the multisystem nature of 'new' BPD necessitates comprehensive long-term follow-up.
- Research into growth factors and stem cells shows promise for future BPD treatment strategies.
Old Vs New Bpd:
Bronchopulmonary dysplasia (BPD) was described about 50 years ago as a fibroproliferative chronic lung disease in consequence of mechanical ventilation/oxygen exposure in premature infants with respiratory distress syndrome (old BPD). Surfactant therapy with increased survival of extremely premature infants identified a new type of an immaturity-related multisystem disorder that is characterized by a stop/simplification of alveolarisation and lung capillary development (new BPD).
Therapy:
To date, mainly symptomatic treatment exists. However, growth factors and stem cell therapy have recently been tested with some success in animal experiments.
Outcome:
Survivors of new BPD may have problems in adult life concerning lung and cardiovascular function, growth and neurosensory and/or motor development.
Related Concept Videos
Pulmonary Cycle: Exhalation
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Breathing
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment

